Development of Clinical Use of Biological Agents on Juvenile Idiopathic Arthritis / 实用儿科临床杂志
Journal of Applied Clinical Pediatrics
;
(24)2004.
Artículo
en Chino
| WPRIM
| ID: wpr-640274
ABSTRACT
Juvenile idiopathic arthritis(JIA)is the most common rheumatology disease in childhood period with poor prognosis.The biological agents are newly developed drugs with features of clear therapeutic targets and fast effects.But its use in JIA is still limited,so this article focuses on the clinical use experience,timming and sideffects of the biological agents on JIA.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Applied Clinical Pediatrics
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS